Delayed treatment with 5-nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione, a glycine site N-methyl-d-aspartate antagonist, protects against permanent middle cerebral artery occlusion in male rats

This publication has 17 references indexed in Scilit:

• The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects
  Behavioural Pharmacology, 2002
• Glutamate release and neuronal damage in ischemia
  Life Sciences, 2001
• Mg2+-dependent modification of the N-methyl-d-aspartate receptor following graded hypoxia in the cerebral cortex of newborn piglets
  Neuroscience, 1999
• Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats
  Neuroscience Letters, 1998
• Middle Cerebral Artery Occlusion in the Rat by Intraluminal Suture
  Stroke, 1996
• Cytoprotective therapies in stroke
  Current Opinion in Neurology, 1995
• The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischemia model
  European Journal of Pharmacology, 1992
• The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat
  Annals of Neurology, 1988
• Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced
  Brain Research, 1988
• Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis
  Journal of Neurochemistry, 1984